Tue, Apr
9 New Articles

Boehringer Ingelheim, one of the world’s 20 leading pharmaceutical companies, and Saniona, a leading biotech company in the field of ion channel drug discovery, announced that they have entered into a research collaborationwith the objective to discover and develop novel compounds for the treatment of schizophrenia.

More Articles ...